Germline Genetic Variation in Etv6 and Predisposition to Childhood Acute Lymphoblastic Leukemia

Takaya Moriyama,Monika Metzger,Gang Wu,Rina Nishii,Maoxiang Qian,Meenakshi Devidas,Wenjian Yang,Emily Quinn,Julie Gastier-Foster,Elizabeth Raetz,Eric C. Larsen,Paul L. Martin,W. Paul Bowman,Naomi J. Winick,Yoshihiro Komada,Elaine R. Mardis,Robert Fulton,Ching-Hon Pui,William E. Evans,Jinghui Zhang,Stephen P. Hunger,Mary V. Relling,Kim E. Nichols,Mignon Loh,Jun J. Yang

DOI: https://doi.org/10.1182/blood.v126.23.695.695

IF: 20.3

2015-01-01

Blood

Abstract:Acute lymphoblastic leukemia (ALL) is the most common cancer in children, and the etiology of this aggressive cancer is not fully understood. Common germline polymorphisms in lymphoid development genes and tumor suppressor genes have been associated with ALL susceptibility, although most have modest effects. Only a small fraction of ALL cases are thought to be related to congenital genetic disorders and consequently hereditary predisposition is rarely considered in clinical practice. However, a growing number of rare germline genetic mutations have been discovered in familial ALL (e.g., PAX5, TP53), raising the possibility that the proportion of ALL attributable to inherited predisposition may be higher than currently proposed. In particular, germline ETV6 variations were recently reported in families with hereditary thrombocytopenia and dramatically increased susceptibility to hematologic malignancies (Nat Genet 2015 47: 180 and 535). ETV6 is a transcriptional repressor essential for hematopoiesis and is frequently targeted by somatic genomic aberrations in childhood ALL (e.g., the ETV6-RUNX1 fusion). Therefore, we sought to comprehensively identify ALL predisposition variants in ETV6 and to determine the extent to which these variants contribute to childhood ALL risk in general.